이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

연구 개요

상태

알려지지 않은

정황

개입 / 치료

상세 설명

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

연구 유형

중재적

등록 (예상)

80

단계

  • 4단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Zhejiang
      • Hangzhou, Zhejiang, 중국, 310009
        • 모병
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 더블

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
위약 비교기: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Postoperative pain score
기간: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
기간: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
기간: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
기간: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
기간: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
기간: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

2차 결과 측정

결과 측정
측정값 설명
기간
Opioid requirement
기간: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
기간: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
기간: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
기간: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
기간: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
기간: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
기간: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
기간: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
기간: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
기간: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
기간: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
기간: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
기간: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
기간: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
기간: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
기간: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
기간: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
기간: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
기간: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
기간: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
기간: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
기간: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
기간: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
기간: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
기간: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
기간: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
기간: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 연구 의자: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (예상)

2019년 8월 1일

기본 완료 (예상)

2019년 12월 31일

연구 완료 (예상)

2020년 12월 31일

연구 등록 날짜

최초 제출

2019년 7월 19일

QC 기준을 충족하는 최초 제출

2019년 7월 31일

처음 게시됨 (실제)

2019년 8월 2일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2019년 8월 2일

QC 기준을 충족하는 마지막 업데이트 제출

2019년 7월 31일

마지막으로 확인됨

2019년 7월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 2019-084

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .